KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Common Equity (2016 - 2025)

Historic Common Equity for Zimmer Biomet Holdings (ZBH) over the last 17 years, with Q3 2025 value amounting to $12.8 billion.

  • Zimmer Biomet Holdings' Common Equity rose 309.13% to $12.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $12.8 billion, marking a year-over-year increase of 309.13%. This contributed to the annual value of $12.5 billion for FY2024, which is 9.53% down from last year.
  • According to the latest figures from Q3 2025, Zimmer Biomet Holdings' Common Equity is $12.8 billion, which was up 309.13% from $12.5 billion recorded in Q2 2025.
  • Zimmer Biomet Holdings' Common Equity's 5-year high stood at $12.8 billion during Q3 2025, with a 5-year trough of $12.0 billion in Q1 2022.
  • Its 5-year average for Common Equity is $12.4 billion, with a median of $12.5 billion in 2024.
  • Its Common Equity has fluctuated over the past 5 years, first surged by 806.77% in 2021, then plummeted by 504.8% in 2022.
  • Over the past 5 years, Zimmer Biomet Holdings' Common Equity (Quarter) stood at $12.7 billion in 2021, then fell by 5.05% to $12.0 billion in 2022, then increased by 3.83% to $12.5 billion in 2023, then fell by 0.1% to $12.5 billion in 2024, then rose by 2.32% to $12.8 billion in 2025.
  • Its Common Equity was $12.8 billion in Q3 2025, compared to $12.5 billion in Q2 2025 and $12.4 billion in Q1 2025.